These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

190 related items for PubMed ID: 28888840

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. Beta-blocker improves survival, left ventricular function, and myocardial remodeling in hypertensive rats with diastolic heart failure.
    Kobayashi M, Machida N, Mitsuishi M, Yamane Y.
    Am J Hypertens; 2004 Dec; 17(12 Pt 1):1112-9. PubMed ID: 15607617
    [Abstract] [Full Text] [Related]

  • 3. Calcineurin inhibitor attenuates left ventricular hypertrophy, leading to prevention of heart failure in hypertensive rats.
    Sakata Y, Masuyama T, Yamamoto K, Nishikawa N, Yamamoto H, Kondo H, Ono K, Otsu K, Kuzuya T, Miwa T, Takeda H, Miyamoto E, Hori M.
    Circulation; 2000 Oct 31; 102(18):2269-75. PubMed ID: 11056104
    [Abstract] [Full Text] [Related]

  • 4. A dipeptidyl peptidase-IV inhibitor improves diastolic dysfunction in Dahl salt-sensitive rats.
    Nakajima Y, Ito S, Asakura M, Min KD, Fu HY, Imazu M, Hitsumoto T, Takahama H, Shindo K, Fukuda H, Yamazaki S, Asanuma H, Kitakaze M.
    J Mol Cell Cardiol; 2019 Apr 31; 129():257-265. PubMed ID: 30880253
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Effects of Teneligliptin on the Progressive Left Ventricular Diastolic Dysfunction in Patients with Type 2 Diabetes Mellitus in Open-Label, Marker-Stratified Randomized, Parallel-Group Comparison, Standard Treatment-Controlled Multicenter Trial (TOPLEVEL Study): Rationale and Study Design.
    Imazu M, Nakano A, Ito S, Hamasaki T, Kitakaze M, TOPLEVEL investigators and study coordinators.
    Cardiovasc Drugs Ther; 2019 Jun 31; 33(3):363-370. PubMed ID: 30850916
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Development of different phenotypes of hypertensive heart failure: systolic versus diastolic failure in Dahl salt-sensitive rats.
    Doi R, Masuyama T, Yamamoto K, Doi Y, Mano T, Sakata Y, Ono K, Kuzuya T, Hirota S, Koyama T, Miwa T, Hori M.
    J Hypertens; 2000 Jan 31; 18(1):111-20. PubMed ID: 10678551
    [Abstract] [Full Text] [Related]

  • 9. Prevention of diastolic heart failure by endothelin type A receptor antagonist through inhibition of ventricular structural remodeling in hypertensive heart.
    Yamamoto K, Masuyama T, Sakata Y, Nishikawa N, Mano T, Hori M.
    J Hypertens; 2002 Apr 31; 20(4):753-61. PubMed ID: 11910313
    [Abstract] [Full Text] [Related]

  • 10. Inhibition of late Na+ current, a novel target to improve diastolic function and electrical abnormalities in Dahl salt-sensitive rats.
    Chi L, Belardinelli L, Zeng A, Hirakawa R, Rajamani S, Ling H, Dhalla AK.
    Am J Physiol Heart Circ Physiol; 2016 May 15; 310(10):H1313-20. PubMed ID: 26993228
    [Abstract] [Full Text] [Related]

  • 11. Temocapril prevents transition to diastolic heart failure in rats even if initiated after appearance of LV hypertrophy and diastolic dysfunction.
    Sakata Y, Yamamoto K, Mano T, Nishikawa N, Yoshida J, Miwa T, Hori M, Masuyama T.
    Cardiovasc Res; 2003 Mar 15; 57(3):757-65. PubMed ID: 12618237
    [Abstract] [Full Text] [Related]

  • 12. Hydrogen gas improves left ventricular hypertrophy in Dahl rat of salt-sensitive hypertension.
    Matsuoka H, Miyata S, Okumura N, Watanabe T, Hashimoto K, Nagahara M, Kato K, Sobue S, Takeda K, Ichihara M, Iwamoto T, Noda A.
    Clin Exp Hypertens; 2019 Mar 15; 41(4):307-311. PubMed ID: 29902079
    [Abstract] [Full Text] [Related]

  • 13. Atorvastatin ameliorates cardiac fibrosis and improves left ventricular diastolic function in hypertensive diastolic heart failure model rats.
    Akahori H, Tsujino T, Naito Y, Matsumoto M, Sasaki N, Iwasaku T, Eguchi A, Sawada H, Hirotani S, Masuyama T.
    J Hypertens; 2014 Jul 15; 32(7):1534-41; discussion 1541. PubMed ID: 24759122
    [Abstract] [Full Text] [Related]

  • 14. Left ventricular strain and transmural distribution of structural remodeling in hypertensive heart disease.
    Ishizu T, Seo Y, Kameda Y, Kawamura R, Kimura T, Shimojo N, Xu D, Murakoshi N, Aonuma K.
    Hypertension; 2014 Mar 15; 63(3):500-6. PubMed ID: 24396022
    [Abstract] [Full Text] [Related]

  • 15. Nicorandil but not ISDN upregulates endothelial nitric oxide synthase expression, preventing left ventricular remodeling and degradation of cardiac function in Dahl salt-sensitive hypertensive rats with congestive heart failure.
    Horinaka S, Kobayashi N, Yagi H, Mori Y, Matsuoka H.
    J Cardiovasc Pharmacol; 2006 May 15; 47(5):629-35. PubMed ID: 16775500
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Gene expression profile revealed different effects of angiotensin II receptor blockade and angiotensin-converting enzyme inhibitor on heart failure.
    Mizukami M, Hasegawa H, Kohro T, Toko H, Kudoh S, Zou Y, Aburatani H, Komuro I.
    J Cardiovasc Pharmacol; 2003 Dec 15; 42 Suppl 1():S1-6. PubMed ID: 14871019
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.